Dr. Yolande Chen
Claim this profileUniversity of Illinois
Studies Cancer
Studies Anal Cancer
7 reported clinical trials
19 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
Stage I
2Anal Cancer
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Yolande Chen is currently running
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting2 awards Phase 32 criteria
Chemotherapy + Radiation
for HIV-Associated Anal Cancer
This trial studies the effects of chemotherapy, radiation, and immunotherapy in treating HIV-associated anal cancer. It targets both low-risk and high-risk patients, aiming to kill cancer cells and help the immune system prevent the cancer from coming back.
Recruiting1 award Phase 2
More about Yolande Chen
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Yolande Chen has experience with
- Fluorouracil
- Capecitabine
- Nivolumab
- Mitomycin
- Intensity-Modulated Radiation Therapy
- Leucovorin Calcium
Breakdown of trials Yolande Chen has run
Cancer
Anal Cancer
Anal Carcinoma
Head and Neck Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yolande Chen specialize in?
Yolande Chen focuses on Cancer and Anal Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Yolande Chen currently recruiting for clinical trials?
Yes, Yolande Chen is currently recruiting for 4 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Yolande Chen has studied deeply?
Yes, Yolande Chen has studied treatments such as Fluorouracil, Capecitabine, Nivolumab.
What is the best way to schedule an appointment with Yolande Chen?
Apply for one of the trials that Yolande Chen is conducting.
What is the office address of Yolande Chen?
The office of Yolande Chen is located at: University of Illinois, Chicago, Illinois 60612 United States. This is the address for their practice at the University of Illinois.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.